Ascendis Pharma A/S (asnd 2.25 04/01/28)
13F holders, Q3 2024 (September 30)1holders −2
0new positions
2sold out
$1.16avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Ascendis Pharma A/S (asnd 2.25 04/01/28) in their 13F filings, down 2 from Q2 2024. 0 opened new positions and 2 sold out. The largest holder was BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.3M).
- Company
- Ascendis Pharma A/S (asnd 2.25 04/01/28)
- CUSIP
- 04351PAD3
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $2.1M |
All 13F filers, Q2 2024 → Q3 2024: 114,909 shares sold, net −114,909 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 2,000,000 | $2.3M |
"% of holder's portfolio" is ASCENDIS PHARMA A/S (ASND 2.25 04/01/28)'s weight in each manager's 13F, not the share of Ascendis Pharma A/S (asnd 2.25 04/01/28) the manager owns.